Explore our resources by research/diagnostic specialty or content type

ALPCO specialists are leveraging their extensive expertise to create a growing collection of resources for your research and testing. Find resources that benefit your work using the handy filters.

News & Events

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings
April 25, 2024

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings

Salem, NH, April 25, 2024 – Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the European Union. This collaboration brings together EUROIMMUN’s extensive distribution network and support infrastructure with ALPCO-GeneProof's innovative molecular diagnostic technologies.

 

ALPCO AAAAI 2024
February 15, 2024

ALPCO at 2024 American Academy of Allergy, Asthma & Immunology(AAAAI) Annual Meeting

As the exclusive North American distributor for Macro Array Diagnostics (MADx), ALPCO is excited to participate in the American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC.

ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay
December 19, 2023

ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay

Salem, NH, December 19, 2023 – American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, proudly announces the commercial launch of its FDA 510(k) cleared Calprotectin Immunoturbidimetric Assay, enhancing its suite of Gastrointestinal (GI) diagnostic solutions.

GeneProof Announces Expansion of its IVDR-Certified PCR Portfolio
October 3, 2023

GeneProof Announces Expansion of its IVDR-Certified PCR Portfolio

GeneProof, a leader in molecular diagnostics, today announced the addition of six new IVDR-certified PCR kits to its expansive portfolio. This comes as a testament to the company’s dedication to delivering its entire portfolio of approximately 80 products as IVDR compliant by 2027.  Currently, 27 products are IVDR cleared, with 16 that are Notified Body certified in class C and B. These include tests for infectious diseases and immuno-compromised/transplant.

ALPCO-GeneProof at AACC 2023
ALPCO receives FDA 510(k) clearance for the Calprotectin Immunoturbidimetric Assay
June 15, 2023

ALPCO receives FDA 510(k) clearance for the Calprotectin Immunoturbidimetric Assay

SALEM, NH, June 15, 2023 - American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, today announced recent FDA 510(k) clearance of its Calprotectin Immunoturbidimetric Assay.

Thermo Fisher partners with ALPCO-GeneProof to broaden their CE-IVD molecular assay portfolio
April 20, 2023

Thermo Fisher partners with ALPCO-GeneProof to broaden their CE-IVD molecular assay portfolio

BRNO, CZECH REPUBLIC, April 17, 2023 – ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust supply chain and support systems.

ALPCO-GeneProof Appoints Erik M. Allen as Chief Executive Officer
April 20, 2023

ALPCO-GeneProof Appoints Erik M. Allen as Chief Executive Officer

SALEM, N.H. and BRNO, Czech Republic, March 30, 2023 /PRNewswire/ -- American Laboratory Products Company, Ltd. ("ALPCO", or the "Company"), a global provider of specialty diagnostic solutions, today announced the appointment of Erik M. Allen as Chief Executive Officer (CEO). Mr. Allen will assume leadership of all aspects of the ALPCO-GeneProof organization in the United States and Europe.

ALPCO + GeneProof Merge to Form a Global Diagnostics Company
September 28, 2022

ALPCO + GeneProof Merge to Form a Global Diagnostics Company

In April of this year, ALPCO proudly announced its merger with GeneProof. Together we are a global leader in immunodiagnostics and molecular diagnostics providing you, our customers, with reagents and proprietary automated sample-to-answer solutions for the tests that matter most to you. Through the depth and breadth of our respective portfolios, ALPCO and GeneProof provide you with t...
AACC 2022
May 16, 2022

AACC 2022

Skip the crowd! Reserve you own one-on-one appointment at AACC for a personalized demo. Schedule here. Featuring New and Exclusive Automated Platforms for Molecular Dx myCROBE is your PCR Laboratory on the Table A fully automated sample-to-result solution for molecular diagnostics with a broad spectrum of diagnostic tests. croBEE 2.0 Nucleic Acid Extraction System is a...